| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $83.2M | — | +2598.7% |
| R&D Expense | $35.0M | — | +42.5% |
| SG&A Expense | $38.3M | — | +8.2% |
| Operating Income | $3.9M | — | +106.6% |
| Pre-tax Income | $5.4M | — | +110.1% |
| Income Tax | $0 | — | — |
| Net Income | $5.4M | — | +110.1% |
| EPS (Basic) | $0.02 | — | +112.5% |
| EPS (Diluted) | $0.01 | — | +106.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $125.4M | -23.6% | +161.4% |
| Short-term Investments | $408.3M | +11.8% | -1.3% |
| Inventory | $15.8M | +38.8% | — |
| Current Assets | $591.5M | +3.5% | +24.4% |
| Total Assets | $610.2M | +2.6% | +23.9% |
| Current Liabilities | $79.5M | -3.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $5.1M | — | +111.9% |
| Investing Cash Flow | -$43.6M | — | -180.5% |
| Financing Cash Flow | $44K | — | -92.0% |
| +50.7% |
| Long-term Debt | $47.3M | +0.3% | — |
| Total Liabilities | $290.7M | +0.5% | +298.0% |
| Stockholders' Equity | $319.6M | +4.5% | -23.8% |